about
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.Alpha-synuclein repeat variants and survival in Parkinson's diseaseGlobal investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson diseaseAlpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control studyIndependent and joint effects of the MAPT and SNCA genes in Parkinson disease.Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study.Association analysis of PARP1 polymorphisms with Parkinson's disease.Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study.Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study.Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson's disease.Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease.Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease.Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease.Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease.Altered glutamate uptake in peripheral tissues from Down syndrome patients.An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy.Fibroblast glutamate transport in aging and in AD: correlations with disease severity.Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients.Is the inverse association between Alzheimer's disease and cancer the result of a different propensity to methylate DNA?Fahr's disease linked to a novel SLC20A2 gene mutation manifesting with dynamic aphasia.A novel heterozygous SETX mutation in a patient presenting with chorea and motor neuron disease.Lymphomonocyte alpha-synuclein levels in aging and in Parkinson diseaseIncreased oxidative stress in lymphocytes from untreated Parkinson's disease patients.Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage
P50
Q33939245-3821912E-D8E5-4560-AB11-1C67486B2D1DQ34231155-292B4676-2754-45BB-9851-86A824CE880CQ34591257-F881518D-5227-4E85-A73E-203E5D389A86Q34670663-86227F1F-A4BC-4A58-B6D4-C8268464B8CCQ34860779-3AEC2BFF-D347-409A-8037-5D3DB1E18638Q35525896-12574E85-8A16-43AD-8143-5FB0A700871BQ35534253-CCAF465C-BBE6-42D1-AFBF-8FC038AECDC6Q35662144-A5D0BFC8-4AB9-4B8F-97C0-AB468E85824CQ35994987-E981FC88-73C6-4819-9BC5-05D1B9A3ECC4Q36426250-0488E7A1-7B23-4688-A0A9-FE5437C9914CQ36708352-73EA2BE1-FA3F-4D95-BAB0-96A745619816Q37312762-12380AF0-3B87-4CD5-9F63-02AE43AFE415Q39469472-E052F484-699C-46F6-AF2A-2ED399E5857BQ42466024-F73A5874-40C7-4AD6-A0B6-F8A8C4CAA436Q42954398-AB552A75-92CE-4A79-8C9E-A0BFB33DD075Q43095357-81E9FBD7-435E-4FCC-8A22-434450A24A85Q44448675-5BE3A30F-7066-4A69-8D77-5E960A1B3C8AQ45102165-93F90698-70B9-426B-95C5-B4D26D6FEDE9Q45271389-CF1B9141-D8F6-40D5-9395-482C0496A18DQ45271393-426122BA-8587-45B3-9389-67F662ABB9F0Q46928536-AC95A074-E7E4-4F5E-940A-FD6609BC3244Q48473911-18528D67-CAC4-443C-88DA-14DCAA08D93AQ54376768-A8BA32FC-032F-4741-8322-EB3DFD22EBB8Q67211869-88C08DD6-6951-4B10-9708-8717D1AA0CE0Q67219103-7C638559-AE27-4BEE-B917-7F076C6DB7BDQ82966221-516CFA82-8CAB-4ACC-A309-694376B9C12D
P50
name
Laura Brighina
@ast
Laura Brighina
@en
Laura Brighina
@es
Laura Brighina
@nl
type
label
Laura Brighina
@ast
Laura Brighina
@en
Laura Brighina
@es
Laura Brighina
@nl
prefLabel
Laura Brighina
@ast
Laura Brighina
@en
Laura Brighina
@es
Laura Brighina
@nl